Researchers at Lawson Research Institute (Lawson), the research arm of St. Joseph's Health Care London, are investigating ...

A COMMON cough medicine could help protect against dementia. A study found that it prevented people with Parkinson’s develop ...

Ambroxol chaperones GCase; in a previous study of people with Parkinson's disease, the drug led to increased GCase levels. It ...

A 12-month study found that Ambroxol helped stabilised psychiatric symptoms and protected against brain damage in genetically ...

A clinical trial has revealed that Ambroxol, a common cough medicine in Europe, may help slow cognitive decline in people with Parkinson’s disease dementia.

A commonly sold cough syrup in Europe could potentially slow down progression of dementia in patients with Parkinson’s ...

Dementia poses a major health challenge with no safe, affordable treatments to slow its progression. Researchers at Lawson ...

Ambroxol supports a key enzyme called glucocerebrosidase (GCase), which is produced by the GBA1 gene. In people with Parkinson's disease, GCase levels are often low.

A cough medicine used for decades in Europe called Ambroxol has shown promise for treating dementia in people with ...

More information: Ambroxol as a Treatment for Parkinson Disease Dementia A Randomized Clinical Trial, JAMA Neurology (2025). DOI: 10.1001/jamaneurol.2025.1687 ...

A commonly sold cough syrup in Europe could potentially slow down progression of dementia in patients with Parkinson’s disease, a new study suggests. Nearly half of those diagnosed with ...